Key Points
International Business Machines maintains a dominant presence in the enterprise hybrid cloud and artificial intelligence consulting markets.
Synopsys provides essential silicon design software and intellectual property that are mission-critical for the semiconductor industry.
Which technology stock is the better choice for your long-term portfolio heading into 2027?
As enterprises rush to integrate artificial intelligence, choosing between a legacy services giant and a specialized software provider is a difficult task for investors. Should you buy International Business Machines (NYSE:IBM) or Synopsys (NASDAQ:SNPS)?
International Business Machines is a leader in enterprise services, with a strong focus on hybrid cloud and consulting. In contrast, Synopsys provides the specialized software and intellectual property needed to design the chips powering modern computing. Both companies are central to the digital economy, yet they offer very different financial profiles and market exposures for you to consider.
The case for International Business Machines
International Business Machines focuses on providing software, consulting, and infrastructure solutions to a global client base. The company serves critical sectors like financial services and healthcare, helping them manage complex hybrid cloud environments. Its strategic ecosystem includes partners such as Adobe (NASDAQ:ADBE), Amazon (NASDAQ:AMZN), Microsoft (NASDAQ:MSFT), Oracle (NYSE:ORCL), Palo Alto Networks (NASDAQ:PANW), Salesforce (NYSE:CRM), Samsung Electronics, and SAP (NYSE:SAP). Additionally, it maintains unique long-term relationships, such as its partnership with the United States Tennis Association.
In FY 2025, revenue reached nearly $67.5 billion, which was an increase of roughly 7.6% over the prior year. The company reported net income of approximately $10.6 billion for the same period. This resulted in a net margin of nearly 15.7%, a significant improvement over earlier years. These figures suggest that the transition toward higher-margin software and consulting services is having a tangible impact on the bottom line.
As of its December 2025 balance sheet, the debt-to-equity ratio was nearly 2.1x, indicating a significant level of total debt relative to shareholder equity. The current ratio, which measures the ability to pay short-term obligations using assets expected to be converted to cash within a year, was approximately 0.9x. For the fiscal year ended in December 2025, the company generated free cash flow of roughly $12.1 billion. This cash generation, defined as cash from operations minus capital expenditures, supports its ability to fund operations and return capital to shareholders.
The case for Synopsys
In the competitive landscape of semiconductor stocks, Synopsys provides essential electronic design automation software and silicon intellectual property. Its tools are used by chip manufacturers and systems companies to design and test complex integrated circuits. The company has secured key relationships, including an intellectual property agreement with Amazon and a strategic partnership with OpenAI. Synopsys also utilizes a global network of channel partners to distribute its specialized engineering software to various vertical markets.
In FY 2025, revenue reached nearly $7.1 billion, representing a significant 15.1% increase over the previous year. The company reported net income of nearly $1.3 billion for the fiscal year. This resulted in a net margin of roughly 18.9%, reflecting the high profitability inherent in specialized software licensing. While revenue growth remains robust, the company continues to navigate the complexities of a changing semiconductor market.
As of its October 2025 balance sheet, the debt-to-equity ratio was approximately 0.5x, suggesting a relatively conservative capital structure. The current ratio was roughly 1.6x, indicating a comfortable margin for meeting short-term financial obligations. For the fiscal year ended in October 2025, free cash flow was nearly $1.3 billion.
Note that stock-based compensation accounted for roughly 58.8% of Synopsys' operating cash flow, inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.
Image source: Getty Images.
Risk profile comparison
IBM faces intense competition in the hybrid cloud and artificial intelligence markets from rivals like Microsoft and Amazon. It depends heavily on research and development innovation to maintain its competitive edge and faces constant threats from cybersecurity incidents. Big Blue also faces risks related to integrating various acquisitions and potential goodwill impairments. Global regulatory pressures regarding data privacy and exposure to currency fluctuations add further layers of risk to its international operations.
Synopsys faces significant risks from its substantial debt burden following its merger with Ansys. The company is exposed to macroeconomic and geopolitical tensions, particularly regarding its operations in China and potential restrictions on technology exports. Revenue volatility is a constant concern due to its dependence on the cyclical semiconductor industry and competition from firms like Keysight Technologies (NYSE:KEYS). Furthermore, Synopsys is currently managing pending securities class action litigation related to the performance of its Design IP segment.
Valuation comparison
International Business Machines trades at a lower Forward P/E, based on future earnings estimates, and a lower P/S ratio, measuring market value against sales over the past twelve months.
| Metric | International Business Machines | Synopsys |
|---|---|---|
| Forward P/E | 20.8x | 24.9x |
| P/S ratio | 3.5x | 9.5x |
Valuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy for 2027?
Spoiler alert: I have been an IBM shareholder since 2015, but I have never owned a share of Synopsys. After comparing the two companies head-to-head in November 2026, I'm not inspired to reverse that balance.
IBM is cheaper, more profitable, and pays a generous dividend. Its annual sales are an order of magnitude larger. The same is true for free cash flow, where IBM generated $14.7 billion over the last four quarters, while Synopsys lagged at $2.7 billion.
I'll admit that Synopsys' sales growth is impressive, and I like the company's AI-assisted engineering expertise. But it can't hold a candle to Big Blue's decades of innovative business growth, and IBM's 36% return on equity puts Synopsys' 3.7% ROE to shame.
I'm comparing a proven cash machine to a barely profitable growth story here. Synopsys deserves respect, but it's not the stock I would recommend in this duel.
Anders Bylund has positions in Amazon and International Business Machines. The Motley Fool has positions in and recommends Adobe, Amazon, International Business Machines, Keysight Technologies, Microsoft, Oracle, Salesforce, and Synopsys. The Motley Fool recommends Palo Alto Networks and recommends the following options: long January 2028 $330 calls on Adobe and short January 2028 $340 calls on Adobe. The Motley Fool has a disclosure policy.